Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Ophthalmic examination, Pulmonary Examination.
- Кому может быть актуально
- Состояния в реестре: Pulmonary Diseases, Ophthalmological Diagnostic Techniques, Artificial Intelligence. Базовые параметры: Без ограничений · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Китай
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Обзор
This study intends to collect ophthalmologic examination results, pulmonary examination results and related indexes from patients with pulmonary disease and control populations, and combine big data analysis and artificial intelligence technology to explore whether new methods can be provided for early screening strategies for pulmonary disease with the aid of ophthalmologic examination, and thus assist in identifying the types of pulmonary disease and determining disease prognosis.
Вмешательства
- Диагностический тест Ophthalmic examination
Various ophthalmic examination modalities, including slit lamp photography, fundus photography, optical coherence tomography imaging and optical coherence tomography angiography, etc. - Диагностический тест Pulmonary Examination
Various pulmonary examination modalities, including radiography, chest CT, pulmonary function measurement, etc.
Первичные конечные точки
- Area Under the Receiver Operating Characteristic curve [Срок оценки: Through study completion, an average of 1 year]
Критерии участия
Критерии включения
- Those aged ≥18 years; or those aged <18 years who can cooperate with the relevant examination and are accompanied and informed by a guardian;
- People with respiratory-related diseases who were to undergo pulmonary examination, or those who volunteered to participate in the trial through publicity recruitment;
- expected survival time of 3 months or more;
- Those with no previous serious underlying disease and no history of serious eye disease;
- Those who can cooperate with ophthalmologic and pulmonary-related examinations and have regular follow-up examinations;
- Those who gave informed consent to the study prior to the trial and voluntarily signed the informed consent form;
- Other conditions that can be included in the study as judged by the investigator.
Критерии исключения
- Patients who are unable to complete ophthalmology or pulmonary-related examinations and regular follow-ups due to serious diseases, trauma or surgery (serious ophthalmology diseases such as extremely poor vision that cannot be fixed, ocular atrophy, severe refractive interstitial clouding that prevents fundus photography, etc.);
- People with poor compliance due to various reasons such as alcohol or drug dependence, or mental disorders;
- Those without informed consent;
- Other conditions judged by the investigator to be unsuitable for participation in the trial.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Да
Дизайн исследования
- Модель наблюдения
- Когортное
Центры проведения
Китай · 4 центра
- Zhongshan Ophthalmic Center, Sun Yat-sen University — Гуанчжоу
- Guangzhou Kindness Health Care Center (Guangzhou Jiubang Shanxin Clinic Ltd) — Гуанчжоу
- the First Affiliated Hospital of Guangzhou Medical University — Гуанчжоу
- Shenzhen Third People's Hospital — Шэньчжэнь
Идентификаторы
NCT: NCT05847894 · 2023KYPJ111